Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Expanded_access × Triple Negative Breast Neoplasms × veliparib × Clear all

Status

No longer available 2

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 10 Expanded_access 2

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2

Interventions

veliparib 2 sacituzumab govitecan 1 iniparib 1 Vinorelbine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03123211 2022-05-24

Expanded Access to Veliparib

AbbVie

No longer available

Triple Negative Breast Neoplasms

NCT02985658 2021-07-21

Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

University of Washington

No longer available

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡